Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Aspira Women's Health Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 657.8K | 715.3K | +57.5K (+8.7%) |
| Value | $3.53M | $2.92M | −$608.5K (−17.3%) |
New holders (5)
Institutions that held Aspira Women's Health Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 15,365 | $62.7K | 0.00% |
| HRT Financial LP | 11,262 | $45.0K | 0.00% |
| Royal Bank of Canada | 9,317 | $38.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 493 | $2.01K | 0.00% |
| FMR LLC | 26 | $106 | 0.00% |
Sold out (5)
Institutions that held Aspira Women's Health Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Perkins Capital Management Inc | 50,000 | $268.0K |
| TownSquare Capital, LLC | 36,809 | $197.3K |
| Susquehanna International Group, LLP | 12,156 | $65.2K |
| Millennium Management LLC | 11,504 | $61.7K |
| Barclays PLC | 30 | $160 |